Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2013 4
2014 5
2015 3
2016 5
2017 11
2018 13
2019 5
2020 14
2021 15
2022 14
2023 15
2024 18
2025 12
2026 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

133 results

Results by year

Filters applied: . Clear all
Page 1
Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis.
Fox RJ, Bar-Or A, Traboulsee A, Oreja-Guevara C, Giovannoni G, Vermersch P, Syed S, Li Y, Vargas WS, Turner TJ, Wallstroem E, Reich DS; HERCULES Trial Group. Fox RJ, et al. N Engl J Med. 2025 May 15;392(19):1883-1892. doi: 10.1056/NEJMoa2415988. Epub 2025 Apr 8. N Engl J Med. 2025. PMID: 40202696 Free article. Clinical Trial.
Ofatumumab versus Teriflunomide in Multiple Sclerosis.
Hauser SL, Bar-Or A, Cohen JA, Comi G, Correale J, Coyle PK, Cross AH, de Seze J, Leppert D, Montalban X, Selmaj K, Wiendl H, Kerloeguen C, Willi R, Li B, Kakarieka A, Tomic D, Goodyear A, Pingili R, Häring DA, Ramanathan K, Merschhemke M, Kappos L; ASCLEPIOS I and ASCLEPIOS II Trial Groups. Hauser SL, et al. N Engl J Med. 2020 Aug 6;383(6):546-557. doi: 10.1056/NEJMoa1917246. N Engl J Med. 2020. PMID: 32757523 Clinical Trial.
Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis.
Steinman L, Fox E, Hartung HP, Alvarez E, Qian P, Wray S, Robertson D, Huang D, Selmaj K, Wynn D, Cutter G, Mok K, Hsu Y, Xu Y, Weiss MS, Bosco JA, Power SA, Lee L, Miskin HP, Cree BAC; ULTIMATE I and ULTIMATE II Investigators. Steinman L, et al. N Engl J Med. 2022 Aug 25;387(8):704-714. doi: 10.1056/NEJMoa2201904. N Engl J Med. 2022. PMID: 36001711 Clinical Trial.
Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials.
Montalban X, Vermersch P, Arnold DL, Bar-Or A, Cree BAC, Cross AH, Kubala Havrdova E, Kappos L, Stuve O, Wiendl H, Wolinsky JS, Dahlke F, Le Bolay C, Shen Loo L, Gopalakrishnan S, Hyvert Y, Javor A, Guehring H, Tenenbaum N, Tomic D; evolutionRMS investigators. Montalban X, et al. Lancet Neurol. 2024 Nov;23(11):1119-1132. doi: 10.1016/S1474-4422(24)00328-4. Epub 2024 Sep 19. Lancet Neurol. 2024. PMID: 39307151 Clinical Trial.
Recommendations for neurological, obstetrical and gynaecological care in women with multiple sclerosis: a statement by a working group convened by the Section of Multiple Sclerosis and Neuroimmunology of the Polish Neurological Society.
Kalinowska A, Kułakowska A, Adamczyk-Sowa M, Czajkowski K, Kurowska K, Pietrzak B, Radziszewski P, Rejdak K, Bartosik-Psujek H. Kalinowska A, et al. Among authors: adamczyk sowa m. Neurol Neurochir Pol. 2020;54(2):125-137. doi: 10.5603/PJNNS.a2020.0015. Epub 2020 Feb 21. Neurol Neurochir Pol. 2020. PMID: 32083716 Free article.
MULTIPLE SCLEROSIS - RISK FACTORS.
Adamczyk-Sowa M, Gębka-Kępińska B, Kępiński M. Adamczyk-Sowa M, et al. Wiad Lek. 2020;73(12 cz 1):2677-2682. Wiad Lek. 2020. PMID: 33577489 Review.
Common pathomechanism of migraine and depression.
Wachowska K, Bliźniewska-Kowalska K, Sławek J, Adamczyk-Sowa M, Szulc A, Maes M, Kuan-Pin S, Gałecki P. Wachowska K, et al. Among authors: adamczyk sowa m. Psychiatr Pol. 2023 Apr 30;57(2):405-419. doi: 10.12740/PP/OnlineFirst/143982. Epub 2023 Apr 30. Psychiatr Pol. 2023. PMID: 36371736 Free article. Review. English, Polish.
Klotho protein in neurodegenerative disorders.
Torbus-Paluszczak M, Bartman W, Adamczyk-Sowa M. Torbus-Paluszczak M, et al. Among authors: adamczyk sowa m. Neurol Sci. 2018 Oct;39(10):1677-1682. doi: 10.1007/s10072-018-3496-x. Epub 2018 Jul 30. Neurol Sci. 2018. PMID: 30062646 Free PMC article. Review.
Recommendations of Multiple Sclerosis and Neuroimmunology Section of the Polish Neurological Society and the Polish Society of Gynecologists and Obstetricians for family planning and pregnancy management in women with multiple sclerosis: an update.
Kalinowska A, Adamczyk-Sowa M, Bartosik-Psujek H, Brola W, Kułakowska A, Mirowska-Guzel D, Nojszewska M, Sieroszewski P, Stasiołek M, Wawrzyniak S, Wender-Ożegowska E. Kalinowska A, et al. Among authors: adamczyk sowa m. Neurol Neurochir Pol. 2026 Aug 18. doi: 10.5603/pjnns.111529. Online ahead of print. Neurol Neurochir Pol. 2026. PMID: 42610722 Free article.
Immunosenescence and multiple sclerosis.
Adamczyk-Sowa M, Nowak-Kiczmer M, Jaroszewicz J, Berger T. Adamczyk-Sowa M, et al. Neurol Neurochir Pol. 2022;56(3):220-227. doi: 10.5603/PJNNS.a2022.0045. Epub 2022 Jun 23. Neurol Neurochir Pol. 2022. PMID: 35735245 Free article.
133 results